Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 279

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 9
Chunk 279
---
ITEM 9.  THE OFFER AND LISTING
A. Offer and Listing Details
 
Our ADSs have been trading on Nasdaq under the symbol “BLRX” since July 2011. Our ordinary shares have been trading on the TASE under the symbol “BLRX” since February 2007.
B. Plan of Distribution
 
Not applicable.
 
C. Markets
 
Our ADSs trade on Nasdaq under the symbol “BLRX.” Our ordinary shares trade on the TASE under the symbol “BLRX.”
 
D. Selling Shareholders
 
Not applicable.
 
E. Dilution
 
Not applicable.
   F. Expenses of the Issue
 
Not applicable.